Point State Capital LP Johnson & Johnson Transaction History

Point State Capital LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$168.19 - $186.01 $9.73 Million - $10.8 Million	57,836 Added 100.0%	115,672 $20.5 Million
Q2 2022 Aug 12, 2022	BUY	$168.19 - $186.01 $9.73 Million - $10.8 Million	57,836 New	57,836 $10.3 Million
Q2 2021 Aug 13, 2021	SELL	$159.48 - $171.07 $5.58 Million - $5.99 Million	-35,000 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$153.07 - $170.48 $1.26 Million - $1.4 Million	-8,200 Reduced 18.98%	35,000 $5.75 Million
Q4 2020 Feb 16, 2021	SELL	$137.11 - $157.38 $17.5 Million - $20.1 Million	-127,785 Reduced 74.73%	43,200 $6.8 Million
Q3 2020 Nov 16, 2020	BUY	$140.38 - $153.83 $2.77 Million - $3.04 Million	19,733 Added 13.05%	170,985 $25.5 Million
Q2 2020 Aug 14, 2020	BUY	$128.81 - $155.51 $19.5 Million - $23.5 Million	151,252 New	151,252 $21.3 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $1.49 Million - $1.71 Million	-11,700 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $1.49 Million - $1.66 Million	11,700 New	11,700 $1.51 Million

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

Stay updated on Point State Capital LP with notifications on news.